68 related articles for article (PubMed ID: 9119899)
21. In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone.
Talpade DJ; Greene JG; Higgins DS; Greenamyre JT
J Neurochem; 2000 Dec; 75(6):2611-21. PubMed ID: 11080215
[TBL] [Abstract][Full Text] [Related]
22. TrkB and TrkC are differentially regulated by excitotoxicity during development of the basal ganglia.
Checa N; Canals JM; Gratacòs E; Alberch J
Exp Neurol; 2001 Dec; 172(2):282-92. PubMed ID: 11716553
[TBL] [Abstract][Full Text] [Related]
23. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.
Bazzett TJ; Becker JB; Kaatz KW; Albin RL
Exp Neurol; 1993 Apr; 120(2):177-85. PubMed ID: 8387931
[TBL] [Abstract][Full Text] [Related]
24. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
Van Kampen JM; McGeer EG; Stoessl AJ
Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
[TBL] [Abstract][Full Text] [Related]
25. Thalidomide inhibition of vascular remodeling and inflammatory reactivity in the quinolinic acid-injected rat striatum.
Ryu JK; Jantaratnotai N; McLarnon JG
Neuroscience; 2009 Oct; 163(2):601-8. PubMed ID: 19591904
[TBL] [Abstract][Full Text] [Related]
26. Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats.
Kalonia H; Kumar P; Kumar A; Nehru B
Neurotoxicology; 2010 Mar; 31(2):195-203. PubMed ID: 20043943
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation in mice of (2-[11C]methoxy)-6',7'-dihydrorotenol, a second generation rotenoid for marking mitochondrial complex I activity.
Charalambous A; Tluczek L; Frey KA; Higgins DS; Greenamyre TJ; Kilbourn MR
Nucl Med Biol; 1995 May; 22(4):491-6. PubMed ID: 7550026
[TBL] [Abstract][Full Text] [Related]
28. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types.
Figueredo-Cardenas G; Harris CL; Anderson KD; Reiner A
Exp Neurol; 1998 Feb; 149(2):356-72. PubMed ID: 9500958
[TBL] [Abstract][Full Text] [Related]
29. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement.
Cleeter MW; Cooper JM; Schapira AH
J Neurochem; 1992 Feb; 58(2):786-9. PubMed ID: 1729421
[TBL] [Abstract][Full Text] [Related]
30. Induction of ferroxidase enzymatic activity by copper reduces MPP+-evoked neurotoxicity in rats.
Rubio-Osornio M; Montes S; Heras-Romero Y; Guevara J; Rubio C; Aguilera P; Rivera-Mancia S; Floriano-Sánchez E; Monroy-Noyola A; Ríos C
Neurosci Res; 2013 Mar; 75(3):250-5. PubMed ID: 23298529
[TBL] [Abstract][Full Text] [Related]
31. Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death.
Kim YJ; Ko HH; Han ES; Lee CS
Brain Res Bull; 2007 Mar; 71(6):633-40. PubMed ID: 17292807
[TBL] [Abstract][Full Text] [Related]
32. Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
Petersén A; Chase K; Puschban Z; DiFiglia M; Brundin P; Aronin N
Exp Neurol; 2002 May; 175(1):297-300. PubMed ID: 12009780
[TBL] [Abstract][Full Text] [Related]
33. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats.
Ceresoli-Borroni G; Guidetti P; Schwarcz R
J Neural Transm (Vienna); 1999; 106(3-4):229-42. PubMed ID: 10392532
[TBL] [Abstract][Full Text] [Related]
34. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults.
Hanbury R; Ling ZD; Wuu J; Kordower JH
J Comp Neurol; 2003 Jun; 461(3):307-16. PubMed ID: 12746870
[TBL] [Abstract][Full Text] [Related]
35. Differential interaction of 1-methyl-4-phenylpyridinium ion with the putatively vesicular binding site of [3H]tyramine in dopaminergic and nondopaminergic brain regions.
Vaccari A; Saba PL; Gessa GL; Del Zompo M
J Neurochem; 1993 Feb; 60(2):758-60. PubMed ID: 8419550
[TBL] [Abstract][Full Text] [Related]
36. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection.
Filloux F; Townsend JJ
Exp Neurol; 1993 Jan; 119(1):79-88. PubMed ID: 8432353
[TBL] [Abstract][Full Text] [Related]
37. Quantitative autoradiography of dihydrorotenone binding to complex I of the electron transport chain.
Greenamyre JT; Higgins DS; Eller RV
J Neurochem; 1992 Aug; 59(2):746-9. PubMed ID: 1629744
[TBL] [Abstract][Full Text] [Related]
38. N-acetylaspartylglutamate (NAAG) protects against rat striatal quinolinic acid lesions in vivo.
Orlando LR; Luthi-Carter R; Standaert DG; Coyle JT; Penney JB; Young AB
Neurosci Lett; 1997 Oct; 236(2):91-4. PubMed ID: 9404819
[TBL] [Abstract][Full Text] [Related]
39. Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10.
Brouillet E; Henshaw DR; Schulz JB; Beal MF
Neurosci Lett; 1994 Aug; 177(1-2):58-62. PubMed ID: 7824183
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparations.
Gluck MR; Krueger MJ; Ramsay RR; Sablin SO; Singer TP; Nicklas WJ
J Biol Chem; 1994 Feb; 269(5):3167-74. PubMed ID: 8106350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
